BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24603802)

  • 1. XIAP antagonist embelin inhibited proliferation of cholangiocarcinoma cells.
    Wehrkamp CJ; Gutwein AR; Natarajan SK; Phillippi MA; Mott JL
    PLoS One; 2014; 9(3):e90238. PubMed ID: 24603802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide and TRAIL combination enhances apoptosis in cholangiocarcinoma.
    Clawson KA; Borja-Cacho D; Antonoff MB; Saluja AK; Vickers SM
    J Surg Res; 2010 Oct; 163(2):244-9. PubMed ID: 20691980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.
    Prabhu KS; Siveen KS; Kuttikrishnan S; Iskandarani A; Tsakou M; Achkar IW; Therachiyil L; Krishnankutty R; Parray A; Kulinski M; Merhi M; Dermime S; Mohammad RM; Uddin S
    PLoS One; 2017; 12(7):e0180895. PubMed ID: 28704451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells.
    Mori T; Doi R; Kida A; Nagai K; Kami K; Ito D; Toyoda E; Kawaguchi Y; Uemoto S
    J Surg Res; 2007 Oct; 142(2):281-6. PubMed ID: 17640673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells.
    Hu R; Zhu K; Li Y; Yao K; Zhang R; Wang H; Yang W; Liu Z
    Med Oncol; 2011 Dec; 28(4):1584-8. PubMed ID: 20625944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptide-conjugated XIAP-inhibitory cyclic hexapeptides enter into Jurkat cells and inhibit cell proliferation.
    Sasaki Y; Minamizawa M; Ambo A; Sugawara S; Ogawa Y; Nitta K
    FEBS J; 2008 Dec; 275(23):6011-21. PubMed ID: 19016849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The XIAP inhibitor Embelin enhances TRAIL-induced apoptosis in human leukemia cells by DR4 and DR5 upregulation.
    Hu R; Yang Y; Liu Z; Jiang H; Zhu K; Li J; Xu W
    Tumour Biol; 2015 Feb; 36(2):769-77. PubMed ID: 25293521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation.
    Yang T; Lan J; Huang Q; Chen X; Sun X; Liu X; Yang P; Jin T; Wang S; Mou X
    Cell Biochem Biophys; 2015 Jan; 71(1):291-7. PubMed ID: 25358405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells.
    Allensworth JL; Aird KM; Aldrich AJ; Batinic-Haberle I; Devi GR
    Mol Cancer Ther; 2012 Jul; 11(7):1518-27. PubMed ID: 22508521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked inhibitor of apoptosis protein inhibitor Embelin induces apoptosis via PI3K/Akt pathway and inhibits invasion in osteosarcoma cells.
    Qian H; Huang T; Chen Y; Li X; Gong W; Jiang G; Zhang W; Cheng S; Li X; Li P
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S648-S655. PubMed ID: 30249882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of human cholangiocarcinoma cell lines induced by β-escin through mitochondrial caspase-dependent pathway.
    Shen DY; Kang JH; Song W; Zhang WQ; Li WG; Zhao Y; Chen QX
    Phytother Res; 2011 Oct; 25(10):1519-26. PubMed ID: 21394804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP.
    Siegelin MD; Gaiser T; Siegelin Y
    Neurochem Int; 2009 Nov; 55(6):423-30. PubMed ID: 19409438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embelin potentiates venetoclax-induced apoptosis in acute myeloid leukemia cells.
    Reis-Silva CSM; Branco PC; Lima K; Silva FL; Moreno PRH; Guallar V; Costa-Lotufo LV; Machado-Neto JA
    Toxicol In Vitro; 2021 Oct; 76():105207. PubMed ID: 34216723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro.
    Fu X; Pang X; Qi H; Chen S; Li Y; Tan W
    Clin Transl Oncol; 2016 Mar; 18(3):277-82. PubMed ID: 26209051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.
    Nikolovska-Coleska Z; Xu L; Hu Z; Tomita Y; Li P; Roller PP; Wang R; Fang X; Guo R; Zhang M; Lippman ME; Yang D; Wang S
    J Med Chem; 2004 May; 47(10):2430-40. PubMed ID: 15115387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells.
    Metwalli AR; Khanbolooki S; Jinesh G; Sundi D; Shah JB; Shrader M; Choi W; Lashinger LM; Chunduru S; McConkey DJ; McKinlay M; Kamat AM
    Cancer Biol Ther; 2010 Nov; 10(9):885-92. PubMed ID: 20814238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Condensed tannins from Ulmus pumila L. leaves induce G2/M phase arrest and apoptosis via caspase-cascade activation in TFK-1 cholangiocarcinoma cells.
    Ren Y; Qin Z; Wang Z; Wei S; Chen H; Zhu T; Liu L; Zhao Y; Ding B; Song W
    J Food Biochem; 2022 Oct; 46(10):e14374. PubMed ID: 35986624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer.
    Rajput S; Kumar BN; Sarkar S; Das S; Azab B; Santhekadur PK; Das SK; Emdad L; Sarkar D; Fisher PB; Mandal M
    PLoS One; 2013; 8(4):e61342. PubMed ID: 23613836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The XIAP inhibitor embelin sensitises malignant rhabdoid tumour cells to TRAIL treatment via enhanced activation of the extrinsic apoptotic pathway.
    Coyle R; Slattery K; Ennis L; O'sullivan MJ; Zisterer DM
    Int J Oncol; 2019 Jul; 55(1):191-202. PubMed ID: 31115498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells.
    Jiang L; Hao JL; Jin ML; Zhang YG; Wei P
    Asian Pac J Cancer Prev; 2013; 14(10):6115-20. PubMed ID: 24289635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.